期刊文献+

大肠癌肝转移临床相关因素分析 被引量:5

Analysis of the Clinical Factors of Hepatic Metastases of Colorectal Cancer
下载PDF
导出
摘要 目的了解大肠癌发生肝转移的临床相关因素。方法对63例发生肝转移及51例未发生转移的大肠癌患者的临床病理资料进行比较分析。结果病程(自出现症状至手术时间)超过半年肝转移率为67.3%,肿瘤低分化者肝转移率为80%,血清CEA、CA199值异常的患者发生肝转移率分别为100%和92.3%,与对照组(无肝转移组)比较,差异有统计学意义(P<0.05),且有淋巴结转移及肿瘤浸润较深者其肝转移率明显升高,差异亦有统计学意义(P<0.05)。结论大肠癌肝转移与患者病程、肿瘤浸润深度、分化程度、淋巴结转移、患者血清CEA、CA199值相关,应针对相关因素积极治疗,加强随访。 Objective To analyze clinical factors of hepatic metastases of colorectal cancer and to guide the individ- ualized and reasonable treatment. Methods 63 cases with hepatic metastases of colorectal cancer were retrospectively reviewed. Results Cases whose disease course over six months have a hepatic metastate rate 67.3 %. Cases with low differentiation have a hepatic metastate rate 80%. Cases with high expression level of CEA and CA199 have a hepatic metastate rate 100% and 92.3% respectively. Condusion For better proguosis,different measures should be taken in patients with different clinical factors.
出处 《宁夏医科大学学报》 2009年第1期58-61,共4页 Journal of Ningxia Medical University
关键词 大肠癌 肝转移 临床相关因素 colorectal cancer hepatic metastases clinical factors
  • 相关文献

参考文献6

二级参考文献27

  • 1莫善兢.早期大肠癌的手术治疗[J].实用肿瘤杂志,1989,4(4):240-241. 被引量:1
  • 2张亚历,聂军,周杰,郭文,关彩平,周殿元.中国青年大肠癌的发病特点及地理分布[J].中华消化内镜杂志,1997,14(1):11-14. 被引量:74
  • 3[1]Ratto C, Sofo L, Ippoliti M,et al. Prognostic factors in colorectal cancer [J ]. Dis Colon Rectum, 1998, 41 ( 8 ):1033.
  • 4[2]Lanza G, Gafa R, Santini A, et al. Prognostic significance of DNA ploidy in patients with stage Ⅱ and stage Ⅲcolon carcinoma[J ]. Cancer, 1998,82(1) :49.
  • 5[3]Lucha PA, Rosen L, Olenwine JA, et al. Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma [J ]. Dis Colon Rectum,1997,40(2) : 145.
  • 6[4]Nilsson D,Johansson C,Glimelins B,et al. Sensitivity and specitivity of CA242 in gastrointestinal cancer. A comparison with CEA. CA50 and CA19-9[J]. Br J Cancer, 1992,65(2) :215.
  • 7[5]Flamini G, Carigliano G, Ratto C, et al. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer[J]. Eur J Cancer, 1996,32A(5) :802.
  • 8[6]Poller DN,Baxter K J, Shepherd NA. p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? [J ]. Br J Cancer, 1997,75 (1): 87.
  • 9[7]Mulder JWR, Kruyt PM, Sewnath M, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins[J ]. Lancet, 1994,344(11): 1470.
  • 10[8]Herrlich P, Pals S, Ponta H. CD44 in colon cancer[J ]. Eur J Cancer, 1995,31A(7~8) : 1110.

共引文献119

同被引文献32

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部